Top popular news today toppopularnewstoday.blogspot.com: Cystic Fibrosis: Charity and Industry Partner for Profit - MedPage Today

MedPage Today Cystic Fibrosis: Charity and Industry Partner for Profit – MedPage Today MedPage Today When a disease-related charity becomes a venture capitalist, regard the pharmaceutical industry among the winners. To illustrate, consider the ‘breakthrough’ cystic fibrosis drug Kalydeco (ivacaftor), which is marketed by Vertex Pharmaceuticals